Loading…
InMed Pharmaceuticals Inc. is projected to decline to $1.62 by 2027, a -1% move from its current price of $1.64. INM is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/13/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 14 | $1.59 | $1.64 | $1.69 | +0.04% |
| Jul 15 | $1.57 | $1.64 | $1.71 | +0.07% |
| Jul 16 | $1.56 | $1.64 | $1.73 | +0.11% |
| Jul 17 | $1.55 | $1.64 | $1.74 | +0.15% |
| Jul 18 | $1.54 | $1.64 | $1.75 | +0.19% |
| Jul 19 | $1.53 | $1.64 | $1.77 | +0.22% |
| Jul 20 | $1.52 | $1.64 | $1.78 | +0.26% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.52 | $1.64 | $1.78 | +0.26% |
| Week 2 | $1.48 | $1.65 | $1.84 | +0.52% |
| Week 3 | $1.45 | $1.65 | $1.89 | +0.78% |
| Week 4 | $1.42 | $1.66 | $1.94 | +1.05% |
| Week 5 | $1.40 | $1.66 | $1.98 | +1.31% |
| Week 6 | $1.38 | $1.67 | $2.01 | +1.57% |
| Week 7 | $1.36 | $1.67 | $2.05 | +1.84% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
InMed Pharmaceuticals Inc. is a clinical stage pharmaceutical company that develops a pipeline of prescription-based cannabinoid products in the United States. The company operates through two segments, InMed Pharmaceuticals and BayMedica Commercial, with the former researching and developing cannabinoid-based pharmaceutical products and the latter developing proprietary manufacturing technologies to produce and sell rare cannabinoids for the health and wellness industry.
Its lead market presence is InMed Pharmaceuticals Inc. (INM), currently priced at $1.57 per share with a market capitalization of $5.2M and a rank of 5033. The stock’s technical footing shows a 50-day simple moving average of $1.19 and a 200-day simple moving average of $1.31, indicating nearby support and trend references.
Looking ahead, the year-by-year forecast shows a climb from a 2026 average of $1.57 toward higher levels in subsequent years, with a bullish tilt emerging in later years and a long-term max forecast well above the current price.
A major floor 62.5% below — a decisive break under it would weaken the trend.
The nearest floor, 9.8% below — buyers have tended to step in here.
Price is pressing into resistance (2.4% away) — a breakout level to watch.
A major ceiling 9.8% above — clearing it would confirm fresh momentum.
Key INM support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of INM market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.65 | Sell | $1.64 | Buy |
| MA 10 | $1.60 | Buy | $1.61 | Buy |
| MA 20 | $1.56 | Buy | $1.56 | Buy |
| MA 50 | $1.33 | Buy | $1.38 | Buy |
| MA 100 | $1.05 | Buy | $1.27 | Buy |
| MA 200 | $1.28 | Buy | $1.52 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 63.42 | Neutral |
| Stoch RSI (14) | 48.41 | Neutral |
| CCI (20) | 107.61 | Buy |
| Williams %R (14) | -17.65 | Info |
| MACD (12,26,9) | -0.00 | Sell |
| ROC (12) | 9.33 | Buy |
| Bollinger %B (20,2) | 0.84 | Neutral |
| Stochastic %K (14) | 82.35 | Sell |
| TRIX (15) | 0.78 | Buy |
| Awesome (5,34) | 0.07 | Buy |
| Ultimate (7,14,28) | 67.01 | Neutral |
| Momentum (10) | 0.13 | Buy |
| Aroon Osc (25) | 52.00 | Buy |
| Hull MA (9) | 1.68 | Sell |
| ADX (14) | 28.66 | Buy |
| ATR (14) | 0.03 | Info |
The 30-day technical picture is neutral, with an RSI of 60. The stock price sits around the converging area of its near-term moving averages, with the 50-day SMA at $1.19 and the 200-day SMA at $1.31. In the near term, the 30-day price range spans $1.25 to $1.97, suggesting limited momentum within a defined band.
Immediate support sits at $0.64 and resistance at $1.73, marking key levels to watch for possible pullbacks or rallies.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.615 | $1.64 | $2.14 | 0% | Neutral | |
| $1.28 | $1.62 | $2.17 | -1% | Neutral | |
| $1.48 | $1.93 | $2.69 | +18% | Neutral | |
| $1.73 | $2.31 | $3.32 | +41% | Bullish | |
| $1.63 | $2.23 | $3.29 | +36% | Bullish | |
| $1.75 | $2.44 | $3.69 | +49% | Bullish | |
| $1.75 | $2.49 | $3.84 | +52% | Bullish | |
| $1.57 | $2.27 | $3.56 | +39% | Bullish | |
| $1.70 | $2.50 | $3.99 | +53% | Bullish | |
| $1.89 | $2.82 | $4.57 | +72% | Bullish | |
| $2.26 | $3.64 | $6.30 | +122% | Bullish | |
| $4.12 | $7.53 | $14.30 | +359% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $0.615 | $1.64 | $2.01 | +0.00% |
| August 2026 | $1.47 | $1.74 | $2.11 | +5.97% |
| September 2026 | $1.42 | $1.70 | $2.09 | -2.38% |
| October 2026 | $1.38 | $1.65 | $2.05 | -2.65% |
| November 2026 | $1.40 | $1.69 | $2.11 | +2.20% |
| December 2026 | $1.40 | $1.69 | $2.14 | +0.29% |
Click any year to see its month-by-month INM forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, INM could reach as high as $2.14, with a base case around $1.64 and support toward $0.615 — roughly 0% from $1.64. A consolidation phase looks the most probable path here.
Expect INM to range from $1.28 to $2.17 through 2027. The $1.62 average target implies a -1% move from current prices. That is -1% versus the projected 2026 average. Price action looks broadly range-bound.
The INM price prediction for 2028 points to an average of $1.93 (low $1.48, high $2.69) — a potential gain of +18% on today's $1.64. A consolidation phase looks the most probable path here.
In 2029, INM is projected to trade between $1.73 and $3.32, averaging $2.31 — a potential gain of +41% from today's $1.64. That is up +20% on the projected 2028 average. Momentum favours further upside here.
InMed Pharmaceuticals Inc.'s 2030 outlook centres on $2.23, within a $1.63 to $3.29 range. That is -3% versus the projected 2029 average. That marks a +36% change versus current levels. Buyers look set to stay in control over this stretch.
By 2031, INM could reach as high as $3.69, with a base case around $2.44 and support toward $1.75 — roughly +49% from $1.64. Momentum favours further upside here.
Expect INM to range from $1.75 to $3.84 through 2032. The $2.49 average target implies a +52% move from current prices. That is up +2% on the projected 2031 average. Buyers look set to stay in control over this stretch.
The INM price prediction for 2033 points to an average of $2.27 (low $1.57, high $3.56) — a potential gain of +39% on today's $1.64. Momentum favours further upside here.
In 2034, INM is projected to trade between $1.70 and $3.99, averaging $2.50 — a potential gain of +53% from today's $1.64. That is up +10% on the projected 2033 average. Buyers look set to stay in control over this stretch.
InMed Pharmaceuticals Inc.'s 2035 outlook centres on $2.82, within a $1.89 to $4.57 range. That is up +13% on the projected 2034 average. That marks a +72% change versus current levels. Momentum favours further upside here.
By 2040, INM could reach as high as $6.30, with a base case around $3.64 and support toward $2.26 — roughly +122% from $1.64. Buyers look set to stay in control over this stretch.
Expect INM to range from $4.12 to $14.30 through 2050. The $7.53 average target implies a +359% move from current prices. That is up +107% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in INM today (≈ 609.756098 INM) could be worth
$4,593.46
+$3,593.46 (+359%) by 2050 · US Dollar
Based on the average projected INM price of $7.53 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in INMwould be worth at today's price.
$1,000 invested in INM on Jul 10, 2025 (≈ 354.609937 INM) would be worth
$581.56
-$418.44 (-41.8%) today · 0.58× · US Dollar
Based on a INM entry price of $2.82 vs. today's $1.64.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.56 | $1,051.28 | +5.1% |
| 1 month ago | $1.51 | $1,086.09 | +8.6% |
| 3 months ago | $0.716 | $2,290.5 | +129.1% |
| 6 months ago | $1.17 | $1,401.71 | +40.2% |
| 1 year ago | $2.82 | $581.56 | -41.8% |
| All time (5.0y) ago | $1,385 | $1.18 | -99.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our INM forecast.
Our base-case forecast reaches $3.30 around 2040.
Implied market cap at $3.30: $17.62M
The multi-year forecast shows a path of progress across several milestones. For 2026, the average price is $1.57 with a neutral sentiment. By 2029, the average rises to $2.17 and the sentiment remains bullish, with a 38% ROI.
In 2030, the average is $2.10 with a 33.8% ROI and bullish sentiment, and by 2040 the forecasted average reaches $3.34 with a 112.6% ROI. By 2050, the average price is forecast at $6.76 with a 330.4% ROI and bullish sentiment, reflecting a long-term upward trajectory. These years illustrate an upside potential, though these figures are estimates, not guarantees, and carry inherent uncertainty and risk.
Tap a question to reveal the answer.
2030 min $1.49, avg $2.10, max $3.21, ROI 33.8%, sentiment BULLISH.
Forecasts show a path from the current price toward higher levels with 2029 avg $2.17 and 2040 avg $3.34, plus 2050 avg $6.76 and ROI up to 330.4%. Sentiment shifts to bullish in later years. These are estimates, not guarantees.
Yes. The forecasted maximums include $6.08 in 2040 and $13.66 in 2050, indicating potential to exceed $5 under the higher-end scenarios.
Current price is $1.57 and market cap is $5.2M.
Sentiment NEUTRAL; RSI14 60; SMA50 $1.19; SMA200 $1.31; 30-day range $1.25-$1.97; support $0.64; resistance $1.73.
InMed Pharmaceuticals Inc. Community Discussion
0Share your InMed Pharmaceuticals Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.